Compared with the 2% amplification rate in the cancer genome atlas (TCGA) primary PCa cohort, the amplification of MUC1 significantly increased in the SU2C CRPC cohort (6%) and the NEPC-enriched CRPC cohort (30%) [147]. This evidence concerns the gene MUC1 and posterior cortical atrophy.